US DOJ drops Viatris unit Mylan from industry-wide antitrust probe
July 2 (Reuters) – Viatris unit Mylan is no longer a subject of the U.S. Department of Justice’s antitrust investigation into alleged price fixing in the generic drug industry, the parent company said on Tuesday. Mylan and several major 비아그라 효과 drugmakers such as Israel’s Teva Pharmaceutical Industries and India’s Sun Pharmaceutical Industries have been […]
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe Read More »